A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction

Journal of Virological Methods

Volumn 112, Issue 1-2, 2003, Pages 45-52

  Jun Bin, Shao ^a   Zhi, Chen ^a   Wei Qin, Ni ^a   Jun, Fan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Covalent closed circular DNA; Hepatitis B virus; Polymerase chain reaction; Real time

Indexed keywords

CIRCULAR DNA; DNA POLYMERASE;

ARTICLE; CHIMERA; CONTROLLED STUDY; GENE AMPLIFICATION; HEPATITIS B VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL DETECTION; STANDARD; TECHNIQUE; VIRUS DETECTION; VIRUS GENOME;

HEPATITIS B VIRUS;

EID: 0242285751     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(03)00190-3     Document Type: Article

References (25)

1. Abdelhamed A.M., Kelley C.M., Miller T.G., Furman P.A., Isom H.C. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. Journal of Virology. 76:2002;8148-8160.
2. Addison W.R., Wong W.W., Fischer K.P., Tyrrell D.L. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus. Antiviral Research. 48:2000;27-37.
3. Bock C.T., Schranz P., Schroder C.H., Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes. 8:1994;215-229.
4. Eckhardt S.G., Milich D.R., McLachlan A. Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. Journal of Virology. 65:1991;575-582.
5. Ganem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annual Review Biochemistry. 56:1987;651-693.
6. Gripon P., Diot C., Theze N., Fourel I., Loreal O., Brechot C., Guguen-Guillouzo C. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. Journal of Virology. 62:1988;4136-4143.
7. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284:1999;825-829.
8. Hoofnagle J.H. Therapy of viral hepatitis. Digestion. 59:1998;563-578.
9. Landers T.A., Greenberg H.B., Robinson W.S. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. Journal of Virology. 23:1977;368-376.
10. Lee C.M., Ong G.Y., Lu S.N., Wang J.H., Liao C.A., Tung H.D., Chen T.M., Changchien C.S. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation. Journal of Hepatology. 37:2002;669-674.
11. Lee K.M., Cho S.W., Kim S.W., Kim H.J., Hahm K.B., Kim J.H. Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion. Journal of Viral Hepatitis. 9:2002;208-212.
12. Ling R., Harrison T.J. Production of hepatitis B virus covalently closed circular DNA in transfected cells is independent of surface antigen synthesis. Journal of General Virology. 78:1997;1463-1467.
13. Newbold J.E., Xin H., Tencza M., Sherman G., Dean J., Bowden S., Locarnini S. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. Journal of Virology. 69:1995;3350-3357.
14. Rijntjes P.J., Moshage H.J., Yap S.H. In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus. Virus Research. 10:1988;95-109.
15. Seigneres B., Pichoud C., Martin P., Furman P., Trepo C., Zoulim F. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses. Hepatology. 36:2002;710-722.
16. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 47:1986;451-460.
17. Van Nunen A.B., Hansen B.E., Suh D.J., Lohr H.F., Chemello L., Fontaine H., Heathcote J., Song B.C., Janssen H.L., De Man R.A., Schalm S.W. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut. 52:2003;420-424.
18. Villamil F.G. Hepatitis B: progress in the last 15 years. Liver Transplantation. 8:2002;S59-66.
19. Wang G.H., Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell. 71:1992;663-670.
20. Wolters L.M., Hansen B.E., Niesters H.G., de Man R.A. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir. European Journal of Gastroenterology Hepatology. 14:2002;1007-1011.
21. Yeh C.T., Chiu H.T., Chu C.M., Liaw Y.F. G1 phase dependent nuclear localization of Relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. Journal of Medical Virology. 55:1998;42-50.
22. Zhu Y., Yamamoto T., Cullen J., Saputelli J., Aldrich C.E., Miller D.S., Litwin S., Furman P.A., Jilbert A.R., Mason W.S. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. Journal of Virology. 75:2001;311-322.
23. Zoulim F., Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. Journal of Virology. 68:1994;6-13.
24. Zoulim F., Berthillon P., Guerhier F.L., Seigneres B., Germon S., Pichoud C., Cheng Y., Trepo C. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies. Journal of Gastroenterology Hepatology. 17:(Suppl 4):2002;S460-S463.
25. Zuckerman A.J., Thomas H.C. Viral Hepatitis. second ed:2001;92 Science press, Beijing.